TRIM24 and dermatomyositis: Patients with dermatomyositis exhibited a rash that corresponded with positive Mi-2, anti-melanoma differentiation-associated protein 5 (MDA5), or anti-transcription intermediary factor-1 (TIF1) antibodies, which were all negative in our case.